Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 61

1.

Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.

Karami J, Mahmoudi M, Amirzargar A, Gharshasbi M, Jamshidi A, Aslani S, Nicknam MH.

Genes Immun. 2017 Sep;18(3):170-175. doi: 10.1038/gene.2017.17. Epub 2017 Aug 10.

PMID:
28794504
2.

BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.

Fu W, Yi S, Qiu L, Sun J, Tu P, Wang Y.

J Invest Dermatol. 2017 Jul;137(7):1523-1532. doi: 10.1016/j.jid.2017.02.980. Epub 2017 Mar 10.

3.

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.

Ha VL, Luong A, Li F, Casero D, Malvar J, Kim YM, Bhatia R, Crooks GM, Parekh C.

Leukemia. 2017 Nov;31(11):2503-2514. doi: 10.1038/leu.2017.70. Epub 2017 Feb 24.

4.

Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.

Dubuissez M, Loison I, Paget S, Vorng H, Ait-Yahia S, Rohr O, Tsicopoulos A, Leprince D.

Mol Cell Biol. 2016 Jun 15;36(13):1881-98. doi: 10.1128/MCB.00062-16. Print 2016 Jul 1.

5.

The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.

Avram D, Califano D.

J Immunol. 2014 Sep 1;193(5):2059-65. doi: 10.4049/jimmunol.1400930. Review.

6.

Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.

Bartram I, Gökbuget N, Schlee C, Heesch S, Fransecky L, Schwartz S, Stuhlmann R, Schäfer-Eckhart K, Starck M, Reichle A, Hoelzer D, Baldus CD, Neumann M.

J Hematol Oncol. 2014 Jul 15;7:51. doi: 10.1186/s13045-014-0051-y.

7.

Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.

Abbas S, Sanders MA, Zeilemaker A, Geertsma-Kleinekoort WM, Koenders JE, Kavelaars FG, Abbas ZG, Mahamoud S, Chu IW, Hoogenboezem R, Peeters JK, van Drunen E, van Galen J, Beverloo HB, Löwenberg B, Valk PJ.

Haematologica. 2014 May;99(5):848-57. doi: 10.3324/haematol.2013.095604. Epub 2014 Jan 17.

8.

Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.

Gu X, Wang Y, Zhang G, Li W, Tu P.

J Dermatol. 2013 Aug;40(8):596-605. doi: 10.1111/1346-8138.12160. Epub 2013 May 19.

PMID:
23682716
9.

Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.

Kurosawa N, Fujimoto R, Ozawa T, Itoyama T, Sadamori N, Isobe M.

PLoS One. 2013;8(1):e55147. doi: 10.1371/journal.pone.0055147. Epub 2013 Jan 30.

10.

BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.

Shen Q, Huang X, Chen S, Yang L, Chen S, Li B, Wu X, Grabarczyk P, Przybylski GK, Schmidt CA, Li Y.

Hematology. 2012 Nov;17(6):329-33. doi: 10.1179/1024533212Z.000000000145.

PMID:
23168072
11.

Role of the transcription factor Bcl11b in development and lymphomagenesis.

Kominami R.

Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):72-87. Review.

12.

Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.

Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Yasmin, Rietzschel ER, Tanaka T, Liu Y, Parsa A, Najjar SS, O'Shaughnessy KM, Sigurdsson S, De Buyzere ML, Larson MG, Sie MP, Andrews JS, Post WS, Mattace-Raso FU, McEniery CM, Eiriksdottir G, Segers P, Vasan RS, van Rijn MJ, Howard TD, McArdle PF, Dehghan A, Jewell ES, Newhouse SJ, Bekaert S, Hamburg NM, Newman AB, Hofman A, Scuteri A, De Bacquer D, Ikram MA, Psaty BM, Fuchsberger C, Olden M, Wain LV, Elliott P, Smith NL, Felix JF, Erdmann J, Vita JA, Sutton-Tyrrell K, Sijbrands EJ, Sanna S, Launer LJ, De Meyer T, Johnson AD, Schut AF, Herrington DM, Rivadeneira F, Uda M, Wilkinson IB, Aspelund T, Gillebert TC, Van Bortel L, Benjamin EJ, Oostra BA, Ding J, Gibson Q, Uitterlinden AG, Abecasis GR, Cockcroft JR, Gudnason V, De Backer GG, Ferrucci L, Harris TB, Shuldiner AR, van Duijn CM, Levy D, Lakatta EG, Witteman JC.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):81-90. doi: 10.1161/CIRCGENETICS.111.959817. Epub 2011 Nov 8.

13.

The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.

Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, Alt FW, Downing JR, Mullighan CG, Look AT.

Blood. 2011 Oct 13;118(15):4169-73. doi: 10.1182/blood-2010-11-318873. Epub 2011 Aug 30.

14.

Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.

Grabarczyk P, Nähse V, Delin M, Przybylski G, Depke M, Hildebrandt P, Völker U, Schmidt CA.

PLoS One. 2010 Sep 2;5(9). pii: e12532. doi: 10.1371/journal.pone.0012532.

15.

CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

Ganguli-Indra G, Wasylyk C, Liang X, Millon R, Leid M, Wasylyk B, Abecassis J, Indra AK.

PLoS One. 2009;4(4):e5367. doi: 10.1371/journal.pone.0005367. Epub 2009 Apr 28. Erratum in: PLoS One. 2009;4(4). doi: 10.1371/annotation/b01c646f-14c7-4aac-8812-9ed4f847c857. Indra, Arup [corrected to Indra, Arup K].

16.

Expression of COUP-TF-interacting protein 2 (CTIP2) in human atopic dermatitis and allergic contact dermatitis skin.

Ganguli-Indra G, Liang X, Hyter S, Leid M, Hanifin J, Indra AK.

Exp Dermatol. 2009 Nov;18(11):994-6. doi: 10.1111/j.1600-0625.2009.00876.x. Epub 2009 Mar 29.

17.

Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.

Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, Siebert R, Dölken G, Ludwig WD, Verhaaf B, van Dongen JJ, Schmidt CA, Langerak AW.

Leukemia. 2005 Feb;19(2):201-8.

PMID:
15668700
18.

BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.

MacLeod RA, Nagel S, Drexler HG.

Cancer Genet Cytogenet. 2004 Aug;153(1):88-9. No abstract available.

PMID:
15325104
19.

A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.

Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap AK, Barge R, Beverstock GC, Rosenberg C.

Cancer Genet Cytogenet. 2004 Feb;149(1):72-6.

PMID:
15104287
20.

Supplemental Content

Support Center